Evidence map›Paper›PMID 39919325›Full record

ArticleBioorganic chemistry2025

Deubiquitinase processing of a non-natural linkage of ubiquitinated-PTEN.

Reina Iwase, Isabella Jaen Maisonet, Kwangwoon Lee, Sara J Buhrlage, Philip A Cole

Abstract read
In one paragraph

Article in Bioorganic chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Reina IwaseDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, United States; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, United States.
Isabella Jaen MaisonetDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, United States; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, United States.
Kwangwoon LeeDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, United States; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, United States.
Sara J BuhrlageDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, United States; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, United States.
Philip A ColeDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, United States; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, United States. Electronic address: pacole@bwh.harvard.edu.

Funding

Chemical Approaches to Protein PhosphorylationR01CA074305 · NCI · JOHNS HOPKINS UNIVERSITY · PI COLE, PHILIP A · 2002 to 2025
$8.0M
ENZYMATIC STUDIES ON PROTEIN TYROSINE KINASE CSKR29CA074305 · NCI · ROCKEFELLER UNIVERSITY · PI COLE, PHILIP A · 1997 to 2001
$188k
NCI NIH HHS R01 CA074305NCI NIH HHS R29 CA074305
6 · The paper itself

Abstract

PTEN is an important tumor suppressor protein that is regulated by ubiquitination events which are modulated by deubiquitinases, or enzymes that remove ubiquitin from substrate proteins. As ubiquitinated substrates are beneficial to study deubiquitinase activity and substrate recognition, we have previously developed a semisynthetic strategy to site-specifically install a monoubiquitin on PTEN. This strategy uses a non-natural aminoAla-Cys functionality as a convenient alternative to the synthetically more challenging natural isopeptide linkage. However, the effective processing of this linkage by deubiquitinases other than by the deubiquitinase USP7 has not been evaluated. Therefore, we assessed whether the aminoAla-Cys linked monoubiquitinated PTEN can be processed by other known deubiquitinases. We found that USP10, USP11, and USP15 processed monoubiquitinated PTEN but BAP1 and OTUD3 could not under the conditions tested. This study demonstrates that ubiquitin linked to the aminoAla-Cys functionality is hydrolyzable by members of the USP family deubiquitinases and enables the systematic evaluation of deubiquitinase activities toward monoubiquitinated protein substrates.

Indexed as

PTEN PhosphohydrolaseUbiquitinationDeubiquitinating EnzymesHumansMolecular StructureThiolester HydrolasesUbiquitinUbiquitin-Specific ProteasesUbiquitin ThiolesteraseDeubiquitinating EnzymesPTEN PhosphohydrolaseThiolester HydrolasesUbiquitinUbiquitin-Specific ProteasesUbiquitin ThiolesteraseUSP10 protein, humanUSP11 protein, humanUSP15 protein, humanDeubiquitinaseProtein SemisynthesisPTENUbiquitin

Identifiers

PMID39919325
PMCPMC11911077

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.